DJIA 17,039.49 60.36 0.36%
NASDAQ 4,532.10 5.62 0.12%
S&P 500 1,992.37 5.86 0.29%
market minute promo

Novartis (NYSE: NVS)

88.95 0.35 (0.40%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVS $88.95 0.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $88.98
Previous Close $88.60
Daily Range $88.90 - $89.35
52-Week Range $72.24 - $91.66
Market Cap $215.8B
P/E Ratio 23.95
Dividend (Yield) $2.72 (2.6%)
Ex-Dividend Date
Dividend Pay Date
02/27/14
04/10/14
Volume 1,985,587
Average Daily Volume 983,974
Current FY EPS $5.21

Sector

Healthcare

Industry

Drugs

Novartis (NVS) Description

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/

News & Commentary Rss Feed

3 Reasons Pfizer Inc.'s Stock Could Rise

Pfizer's stock may appear stagnant, but these three catalysts could be the formula which send its shares significantly higher.

Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 22, 2014

Pre-Market Activity Shows Heavy Volume And Movement For Novartis (NVS)

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, T

Pre-Market Most Active for Aug 21, 2014 : NVS, BAC, MCC, HTZ, DG, JRJC, NOK, AAPL, QQQ, DLTR, FB, TVIX

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Apricus Biosciences' ED Treatment Vitaros Now in Germany - Analyst Blog

Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog

European ADRs Decline, Led By Mining Companies

Why Novartis (NVS) Stock Is Gaining Today

Sector Update: Health Care Stocks Finish on Plus Side; Apricus Gains Following Commercial Launch in

Sector Update: Health Care Stocks Finish on Plus Side; Apricus Gains Following Commercial Launch in Germany

See More NVS News...

NVS's Top Competitors

NVS $88.95 (0.40%)
Current stock: NVS
JNJ $104.19 (0.95%)
Current stock: JNJ
MRK $58.85 (-1.06%)
Current stock: MRK
GSK $47.70 (-0.23%)
Current stock: GSK